JPM 2024: Pharma CEOs face a crossroads

With the 2024 J.P. Morgan Healthcare Conference underway, MM+M’s Marc Iskowitz provides an update from on the ground in San Francisco. Digital Editor Jack O’Brien talks with Insilico Medicine President Michelle Chen about the company’s ongoing work to bring generative AI’s capabilities to the world of clinical research. 

Senior Reporter Lecia Bushak talks about the Food and Drug Administration’s historic move to give Florida the ability to import medications from Canada at much lower prices than in the U.S.

Eli Lilly’s LillyDirect website launch marks a direct-to-consumer push for GLP-1 drugs like Zepbound, we dive into Defense Secretary Lloyd Austin’s controversial prostate cancer treatment saga and examine the brands and influencers toasting to Dry January.

Check us out at: mmm-online.com

Follow us:

YouTube: @MMM-online

TikTok: @MMMnews

Instagram: @MMMnewsonline

Twitter/X: @MMMnews

LinkedIn: MM+M

To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

Music: “Deep Reflection” by DP and Triple Scoop Music.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.